FDA Asks Federal Judge to Grant It until the Year 2076 To Fully Release Pfizer’s Covid-19 Vaccine Data
The US has purchased 10 million courses of Pfizer’s Covid treatment tablet, an oral antiviral medicine that proved highly effective in reducing hospitalisation among high-risk adults in a clinical trial, President Joe Biden stated on Thursday
It is possible that the tablet, Paxlovid, could radically transform the fight against the virus because it provides doctors with a medicine that patients can take home after infection. The current outbreak of delta infections has put a lot of strain on hospitals, and a highly effective at-home treatment could alleviate some of that burden.
$5.29 billion deal with the U.S. government
COVID-19, an experimental antiviral medicine developed by Pfizer Inc, has been approved by the FDA for use in the United States, and the company has inked a $5.29 billion contract with the government to supply 10 million courses of the drug.
“It’s good to hear this. President Joe Biden stated in a statement Thursday that this medication could be another key tool in our armoury that helps speed our route out of the pandemic.
Merck & Co Inc has a contract with the U.S. government worth about twice as much as Pfizer, yet the Pfizer tablet costs approximately $530 each course, and Merck’s costs about $700.
When Pfizer reported statistics demonstrating that the medicine, Paxlovid, was 89% successful in reducing hospitalizations or deaths among those who were at high risk, they sought for emergency authorization of the prescription.
Why is Biogen’s stock so hot right now? : Biotech’s Controversial Alzheimer’s Disease Drug
Vice President Joe Biden said his administration is making the necessary preparations now to ensure that these treatments are accessible and free. “It’s good to hear this. As a new weapon in our battle against the epidemic, this medication could prove to be a game changer.”
The supply of the pills will begin at the end of this year and will continue through 2022, according to Biden’s announcement.
It was filed to the FDA on Tuesday, and Pfizer hopes that the agency will issue it an emergency licence. Ritonavir is a common HIV medication that is used with Paxlovid.
89 percent of the time, Paxlovid prevented hospitalisation and mortality in persons 18 and older who were more likely to get severe Covid, according to a clinical trial conducted by Pfizer. Ritonavir is a common HIV medication that is used with Paxlovid.
Be the first to comment